These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1695222)

  • 1. Binding behaviour of antibodies reacting specifically with an immunodominant region of the transmembrane protein gp41 of HIV-1.
    Döpel SH; Porstmann T; Grunow R; Henklein P; Pas P; von Baehr R
    J Virol Methods; 1990 May; 28(2):189-98. PubMed ID: 1695222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies.
    Xu JY; Gorny MK; Palker T; Karwowska S; Zolla-Pazner S
    J Virol; 1991 Sep; 65(9):4832-8. PubMed ID: 1714520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals.
    Calarota S; Jansson M; Levi M; Broliden K; Libonatti O; Wigzell H; Wahren B
    AIDS Res Hum Retroviruses; 1996 May; 12(8):705-13. PubMed ID: 8744581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates.
    Horal P; Svennerholm B; Jeansson S; Rymo L; Hall WW; Vahlne A
    J Virol; 1991 May; 65(5):2718-23. PubMed ID: 1707985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of anti-gp41 core structure antibodies, which compete with sera of HIV-1-infected patients.
    Usami O; Xiao P; Ling H; Liu Y; Nakasone T; Hattori T
    Microbes Infect; 2005 Apr; 7(4):650-7. PubMed ID: 15823513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy.
    Oldstone MB; Tishon A; Lewicki H; Dyson HJ; Feher VA; Assa-Munt N; Wright PE
    J Virol; 1991 Apr; 65(4):1727-34. PubMed ID: 2002540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
    Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
    Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro.
    Robinson WE; Kawamura T; Lake D; Masuho Y; Mitchell WM; Hersh EM
    J Virol; 1990 Nov; 64(11):5301-5. PubMed ID: 1698995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity of anti-human immunodeficiency virus type 1 gp41 antibodies with human astrocytes and astrocytoma cell lines.
    Spehar T; Strand M
    J Virol; 1994 Oct; 68(10):6262-9. PubMed ID: 8083966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.
    Bell SJ; Cooper DA; Kemp BE; Doherty RR; Penny R
    Clin Exp Immunol; 1992 Jan; 87(1):37-45. PubMed ID: 1370773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.
    Nyambi PN; Mbah HA; Burda S; Williams C; Gorny MK; Nádas A; Zolla-Pazner S
    J Virol; 2000 Aug; 74(15):7096-107. PubMed ID: 10888650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes.
    Alam SM; McAdams M; Boren D; Rak M; Scearce RM; Gao F; Camacho ZT; Gewirth D; Kelsoe G; Chen P; Haynes BF
    J Immunol; 2007 Apr; 178(7):4424-35. PubMed ID: 17372000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41.
    Rey-Cuillé MA; Svab J; Benferhat R; Krust B; Briand JP; Muller S; Hovanessian AG
    J Pharm Pharmacol; 2006 Jun; 58(6):759-67. PubMed ID: 16734977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro.
    Robinson WE; Gorny MK; Xu JY; Mitchell WM; Zolla-Pazner S
    J Virol; 1991 Aug; 65(8):4169-76. PubMed ID: 2072448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
    Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
    AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV.
    Mitchell WM; Ding L; Gabriel J
    AIDS; 1998 Jan; 12(2):147-56. PubMed ID: 9468363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro.
    Robinson WE; Kawamura T; Gorny MK; Lake D; Xu JY; Matsumoto Y; Sugano T; Masuho Y; Mitchell WM; Hersh E
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3185-9. PubMed ID: 2326277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human immunodeficiency virus type 1 glycoprotein gp120/gp41 interacting sites by the idiotypic mimicry of two monoclonal antibodies.
    Lopalco L; Longhi R; Ciccomascolo F; De Rossi A; Pelagi M; Andronico F; Moore JP; Schulz T; Beretta A; Siccardi AG
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):33-9. PubMed ID: 7678970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.